Bayer Aktiengesellscha Valuation
| BAYZF Stock | USD 28.97 0.31 1.06% |
At this time, the firm appears to be fairly valued. Bayer Aktiengesellschaft shows a prevailing Real Value of $29.69 per share. The current price of the firm is $28.97. Our model approximates the value of Bayer Aktiengesellschaft from analyzing the firm fundamentals such as Current Valuation of 87.41 B, profit margin of 0.09 %, and Return On Equity of 0.13 as well as examining its technical indicators and probability of bankruptcy. In general, most investors favor locking in undervalued instruments and disposing overvalued instruments since, at some point, asset prices and their ongoing real values will blend.
Fairly Valued
Today
Please note that Bayer Aktiengesellscha's price fluctuation is very steady at this time. Calculation of the real value of Bayer Aktiengesellschaft is based on 3 months time horizon. Increasing Bayer Aktiengesellscha's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Bayer Aktiengesellschaft is useful when determining the fair value of the Bayer pink sheet, which is usually determined by what a typical buyer is willing to pay for full or partial control of Bayer Aktiengesellscha. Since Bayer Aktiengesellscha is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Bayer Pink Sheet. However, Bayer Aktiengesellscha's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 28.97 | Real 29.69 | Hype 28.97 | Naive 27.72 |
The real value of Bayer Pink Sheet, also known as its intrinsic value, is the underlying worth of Bayer Aktiengesellschaft Company, which is reflected in its stock price. It is based on Bayer Aktiengesellscha's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Bayer Aktiengesellscha's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Bayer Aktiengesellscha's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Bayer Aktiengesellschaft helps investors to forecast how Bayer pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Bayer Aktiengesellscha more accurately as focusing exclusively on Bayer Aktiengesellscha's fundamentals will not take into account other important factors: Bayer Aktiengesellscha Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Bayer Aktiengesellscha's current stock value. Our valuation model uses many indicators to compare Bayer Aktiengesellscha value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Bayer Aktiengesellscha competition to find correlations between indicators driving Bayer Aktiengesellscha's intrinsic value. More Info.Bayer Aktiengesellschaft is number one stock in price to earning category among related companies. It is number one stock in price to book category among related companies . The ratio of Price To Earning to Price To Book for Bayer Aktiengesellschaft is about 236.60 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Bayer Aktiengesellscha by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Bayer Aktiengesellscha's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Bayer Aktiengesellscha's earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Bayer Aktiengesellscha's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Bayer Aktiengesellscha and how it compares across the competition.
About Bayer Aktiengesellscha Valuation
The pink sheet valuation mechanism determines the current worth of Bayer Aktiengesellschaft on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Bayer Aktiengesellschaft. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Bayer Aktiengesellschaft based exclusively on its fundamental and basic technical indicators. By analyzing Bayer Aktiengesellscha's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Bayer Aktiengesellscha's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Bayer Aktiengesellscha. We calculate exposure to Bayer Aktiengesellscha's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Bayer Aktiengesellscha's related companies.Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany. Bayer Ag is traded on OTC Exchange in the United States.
8 Steps to conduct Bayer Aktiengesellscha's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Bayer Aktiengesellscha's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Bayer Aktiengesellscha's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Bayer Aktiengesellscha's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Bayer Aktiengesellscha's revenue streams: Identify Bayer Aktiengesellscha's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Bayer Aktiengesellscha's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Bayer Aktiengesellscha's growth potential: Evaluate Bayer Aktiengesellscha's management, business model, and growth potential.
- Determine Bayer Aktiengesellscha's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Bayer Aktiengesellscha's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
A single share of Bayer Aktiengesellscha represents a small ownership stake in the entity. As a stockholder of Bayer, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.
Bayer Aktiengesellscha Dividends Analysis For Valuation
Please note that Bayer Aktiengesellscha has scaled down on payment of dividends at this time.
There are various types of dividends Bayer Aktiengesellscha can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of Bayer shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from Bayer Aktiengesellschaft directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When Bayer pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of Bayer Aktiengesellscha by the value of the dividends paid out.
Bayer Aktiengesellscha Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Bayer Aktiengesellscha does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 982.4 M | |
| Quarterly Earnings Growth Y O Y | 5.424 | |
| Forward Price Earnings | 6.5876 | |
| Retained Earnings | 13.3 B |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bayer Aktiengesellschaft. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the Bayer Aktiengesellschaft information on this page should be used as a complementary analysis to other Bayer Aktiengesellscha's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Complementary Tools for Bayer Pink Sheet analysis
When running Bayer Aktiengesellscha's price analysis, check to measure Bayer Aktiengesellscha's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bayer Aktiengesellscha is operating at the current time. Most of Bayer Aktiengesellscha's value examination focuses on studying past and present price action to predict the probability of Bayer Aktiengesellscha's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bayer Aktiengesellscha's price. Additionally, you may evaluate how the addition of Bayer Aktiengesellscha to your portfolios can decrease your overall portfolio volatility.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Stocks Directory Find actively traded stocks across global markets | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |